Optimization of arylindenopyrimidines as potent adenosine A2A/A1 antagonists
摘要:
Two reactive metabolites were identified in vivo for the dual A(2A)/A(1) receptor antagonist 1. Two strategies were implemented to successfully mitigate the metabolic liabilities associated with 1. Optimization of the arylindenopyrimidines led to a number of amide, ether, and amino analogs having comparable in vitro and in vivo activity. (C) 2010 Elsevier Ltd. All rights reserved.
Optimization of arylindenopyrimidines as potent adenosine A2A/A1 antagonists
摘要:
Two reactive metabolites were identified in vivo for the dual A(2A)/A(1) receptor antagonist 1. Two strategies were implemented to successfully mitigate the metabolic liabilities associated with 1. Optimization of the arylindenopyrimidines led to a number of amide, ether, and amino analogs having comparable in vitro and in vivo activity. (C) 2010 Elsevier Ltd. All rights reserved.
A one-pot electronically controlled [4 + 2] cycloaddition reaction of in situ generated benzyne with 2-arylidene-1-indenone is unveiled to construct novel spirocyclic frameworks in a regio- and diastereoselective fashion. This protocol features operational simplicity, good functional group tolerance and avoids the use of metal catalysts and external additives. This methodology has extended the synthetic
揭示了原位生成的苯与 2-亚芳基-1-茚酮的单锅电子控制 [4 + 2] 环加成反应,以区域和非对映选择性方式构建新型螺环框架。该协议具有操作简单、良好的官能团耐受性并避免使用金属催化剂和外部添加剂的特点。这种方法扩展了 2-arylidene-1-indenones 的合成应用,可以轻松获得有价值的 10' H -spiro[indene-2,9'-phenanthren]-1(3 H )-ones 并获得高产率。